News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Naveen Pemmaraju shares new report on oral DAC+VEN for BPDCN published in Leukemia and Lymphoma Journal
Naveen Pemmaraju and Hannah Goulart
May 6, 2025, 17:55

Naveen Pemmaraju shares new report on oral DAC+VEN for BPDCN published in Leukemia and Lymphoma Journal

Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center, shared an article co-authored by Hannah Goulart et al. on LinkedIn:

“Delighted to share our brand new original report  just published in Leukemia and Lymphoma, led by Dr Hannah Goulart and Dr Naveen Pemmaraju, MD oral DAC+VEN for patients with BPDCN”

Title: A case series of oral decitabine–cedazuridine with venetoclax for blastic plasmacytoid dendritic cell neoplasm

Journal: Leukemia and Lymphoma

Authors: Hannah Goulart, Guillermo Garcia-Manero, Tapan M. Kadia, Naval Daver, Courtney D. DiNardo, Farhad Ravandi, Muzaffar Qazilbash, Caitlin Rausch, Gabriela Llaurador Caraballo, Sherry Pierce, Naveen Pemmaraju

Read the full article.

Naveen Pemmaraju

Learn more about blastic plasmacytoid dendritic cell neoplasm on OncoDaily.

Blastic Plasmacytoid Dendritic Cell Neoplasm BPDCN Caitlin Rausch cancer Courtney D. DiNardo Farhad Ravandi Gabriela Llaurador Caraballo Guillermo Garcia-Manero Hannah Goulart MD Anderson Cancer Center Muzaffar Qazilbash Naval Daver Naveen Pemmaraju OncoDaily Oncology Sherry Pierce Tapan M. Kadia
Special Coverage
Blog
May 7, 2025, 09:58
Miguel Bronchud: Cancer Research UK Report on Brexit’s Impact on Clinical Trials
Blog
May 7, 2025, 09:49
Luis E Raez: Congrats to our fellows for EGFR review in NCODA
Blog
May 7, 2025, 09:48
Stephen Liu: IASLC Podcast Spotlight - Dr. Bryant Lin’s Personal and Professional Journey with Lung Cancer
Blog
May 7, 2025, 09:47
Estela Rodriguez: Thank You to All The Nurses For Your Dedication, Compassion, and Hard Work
Blog
May 7, 2025, 09:45
Wendy Lichtenthal: American Psychological Associations Population-Health Training Series on Grief Informed Care
Blog
May 7, 2025, 09:31
What Happens When a Lung Cancer Awareness Advocate Becomes a Patient? - IASLC 
Blog
May 7, 2025, 09:31
6th EORTC Quality of Life in Cancer Clinical Trials Conference Will Take Place at the Hilton Barcelona in Spain
Science
May 7, 2025, 09:26
Aaron Hansen: New Chemotherapy Database to Monitor Ovarian Cancer Treatment in New Zealand
Blog
May 7, 2025, 09:23
Brendon Stiles: Now is NOT The Time to Let Up On Research And Clinical Trials Or On Efforts to Better Identify and Screen at Risk Patients
Blog
May 7, 2025, 09:13
Jasna But Hadzic: Strong Slovenian Presence at ESTRO 2025
Blog
May 7, 2025, 09:13
Ruben Mesa: This Year My Perspective on Melanoma and Skin Cancer Awareness Month is Much More Personal
Science
May 7, 2025, 09:10
Circulating Tumor DNA Clearance as a Predictive Biomarker of Pathologic Complete Response in Solid Tumors Treated with Neoadjuvant ICIs